8FPX image
Deposition Date 2023-01-05
Release Date 2024-06-05
Last Version Date 2024-09-04
Entry Detail
PDB ID:
8FPX
Title:
Crystal structure of tumor related RhoA mutant A161P in complex with GDP
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.47 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transforming protein RhoA
Gene (Uniprot):RHOA
Mutations:F25N, A161P
Chain IDs:A
Chain Length:183
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Tumor-derived RHOA mutants interact with effectors in the GDP-bound state.
Nat Commun 15 7176 7176 (2024)
PMID: 39169042 DOI: 10.1038/s41467-024-51445-z

Abstact

RHOA mutations are found at diverse residues in various cancer types, implying mutation- and cell-specific mechanisms of tumorigenesis. Here, we focus on the underlying mechanisms of two gain-of-function RHOA mutations, A161P and A161V, identified in adult T-cell leukemia/lymphoma. We find that RHOAA161P and RHOAA161V are both fast-cycling mutants with increased guanine nucleotide dissociation/association rates compared with RHOAWT and show reduced GTP-hydrolysis activity. Crystal structures reveal an altered nucleotide association in RHOAA161P and an open nucleotide pocket in RHOAA161V. Both mutations perturb the dynamic properties of RHOA switch regions and shift the conformational landscape important for RHOA activity, as shown by 31P NMR and molecular dynamics simulations. Interestingly, RHOAA161P and RHOAA161V can interact with effectors in the GDP-bound state. 1H-15N HSQC NMR spectra support the existence of an active population in RHOAA161V-GDP. The distinct interaction mechanisms resulting from the mutations likely favor an RHOAWT-like "ON" conformation, endowing GDP-bound state effector binding activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures